OrganoTherapeutics Newsletter November 2025 ; First FDA IND Based Solely on Human Vascularized Organoid Data

We present November’s edition of our monthly newsletter.

This month, we talk about the Approval of drugs by the FDA and the use of organoid Data for developing drugs.

To read it, please click here.

Previous
Previous

OrganoTherapeutics December 2025 ; Synapses and their detection in organoid models

Next
Next

OrganoTherapeutics Newsletter September 2025 ; Brain vasculature and midbrain-vascular assembloids.